Insider Transactions in Q3 2024 at Viemed Healthcare, Inc. (VMD)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 25
2024
|
Bruce D Greenstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,719
+12.27%
|
-
|
|
Aug 25
2024
|
Nitin Kaushal Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,719
+7.79%
|
-
|
|
Aug 25
2024
|
William Frazier Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
876
-1.28%
|
$6,132
$7.39 P/Share
|
|
Aug 25
2024
|
William Frazier Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,594
+4.97%
|
-
|
|
Aug 25
2024
|
Randy E. Dobbs Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,611
+10.48%
|
-
|
|
Aug 25
2024
|
Timothy Smokoff Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,719
+10.47%
|
-
|
|
Aug 25
2024
|
Sabrina Heltz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,719
+17.16%
|
-
|
|
Aug 22
2024
|
Jeremy Trahan General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,813
-14.05%
|
$12,691
$7.22 P/Share
|
|
Aug 22
2024
|
Jeremy Trahan General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
8,958
+27.39%
|
-
|
|
Aug 22
2024
|
Jeremy Trahan General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,986
-30.11%
|
$20,902
$7.22 P/Share
|